STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION (EIN 25-1462312)
Tax period
2015-07-01 to 2016-06-30
Filed
2017-03-29
IRS object ID
201720899349300322
Schema version
2015v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-03-29T12:29:33-07:00ReturnTs
Tax Period End2016-06-30TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2015-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN251462312EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlMAGEBusinessNameControlTxt
Phone4126418957PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line13339 Ward StreetAddressLine1Txt
CityPittsburghCityNm
State AbbreviationPAStateAbbreviationCd
ZIP15213ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonArthur Scully IIIPersonNm
Person TitleVice PresidentPersonTitleTxt
Phone4126418949PhoneNum
Signature2017-03-29SignatureDt
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerMichael Annichine CEOPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line13339 Ward StreetAddressLine1Txt
CityPittsburghCityNm
State AbbreviationPAStateAbbreviationCd
ZIP15213ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$69,001,257GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.mageewomens.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1984FormationYr
Legal Domicile StatePALegalDomicileStateCd
Activity Or MissionMagee-Womens Research Institute (MWRI), the first and largest research institute in the U.S. devoted exclusively to women's health, is a recognized leader conducting unprecedented research and advancing clinical knowledge in many areas affecting women, including: reproductive biology, breast cancer, ovarian cancer, genomics and personalized therapies, HIV immunization and prevention, fertility preservation, and pelvic floor research. Magee-Womens Research Institute is dedicated to the transformation of health research for the good of all humankind .ActivityOrMissionDesc
Voting Members Governing Body25VotingMembersGoverningBodyCnt
Voting Members Independent22VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers231TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$58,771,738PYContributionsGrantsAmt
CY Contributions Grants$48,885,965CYContributionsGrantsAmt
PY Program Service Revenue$541,808PYProgramServiceRevenueAmt
CY Program Service Revenue$373,199CYProgramServiceRevenueAmt
PY Investment Income$2,071,799PYInvestmentIncomeAmt
CY Investment Income$1,917,924CYInvestmentIncomeAmt
PY Other Revenue$747,022PYOtherRevenueAmt
CY Other Revenue$734,444CYOtherRevenueAmt
PY Total Revenue$62,132,367PYTotalRevenueAmt
CY Total Revenue$51,911,532CYTotalRevenueAmt
PY Grants And Similar Paid$32,933,713PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$28,738,678CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$14,277,186PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$14,208,909CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$814,635CYTotalFundraisingExpenseAmt
PY Other Expenses$14,922,243PYOtherExpensesAmt
CY Other Expenses$13,113,335CYOtherExpensesAmt
PY Total Expenses$62,133,142PYTotalExpensesAmt
CY Total Expenses$56,060,922CYTotalExpensesAmt
PY Revenues Less Expenses-$775PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$4,149,390CYRevenuesLessExpensesAmt
Total Assets BOY$100,005,983TotalAssetsBOYAmt
Total Assets EOY$92,483,980TotalAssetsEOYAmt
Total Liabilities BOY$49,856,841TotalLiabilitiesBOYAmt
Total Liabilities EOY$47,958,056TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$50,149,142NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$44,525,924NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionThe Board approved mission of MWRIF is to advance scientific knowledge in the fields of reproductive biology and medicine; translate this knowledge into improved health for women and infants; train current and future scholars of reproductive sciences; and foster community investment and involvement in women's health.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$50,326,198ExpenseAmt
Grant$28,738,678GrantAmt
Revenue$1,235,780RevenueAmt
DescSee Schedule ODesc
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$50,326,198TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent EndowmentsYes (1)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (1)ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document46IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members25GoverningBodyVotingMembersCnt
Independent Voting Member22IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonLisa Ascencio Director of FinancePersonNm
Phone4126418957PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line13339 Ward StreetAddressLine1Txt
CityPittsburghCityNm
State AbbreviationPAStateAbbreviationCd
ZIP15213ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Theresa Bone
Director10Yes (X)$0$0$0
Andrew Carey-Jaja
Director10Yes (X)$0$0$0
Leslie Davis
Director10Yes (X)$0$0$0
Robert Edwards
Director20Yes (X)$0$0$0
Joan Ellenbogen
Director10Yes (X)$0$0$0
Laura Ellsworth
Director10Yes (X)$0$0$0
Margaret Joy
Director2.50Yes (X)$0$0$0
Karen Kelley
Director10Yes (X)$0$0$0
Joan Snyder Kuhl
Director10Yes (X)$0$0$0
Ed Lettieri
Director10Yes (X)$0$0$0
Arthur Levine
Director10Yes (X)$0$0$0
Susan McGalla
Director10Yes (X)$0$0$0
Linda S Melada
Director10Yes (X)$0$0$0
William Pietragallo
Director10Yes (X)$0$0$0
K Scott Roy
Director10Yes (X)$0$0$0
W Scott Sanford
Director10Yes (X)$0$0$0
Patricia Siger
Director10Yes (X)$0$0$0
David Spigelmyer
Director10Yes (X)$0$0$0
Jason Harrison
Treasurer2.50Yes (X)$0$0$0Yes (X)
Peggy Snavely
Secretary10Yes (X)$0$0$0Yes (X)
Carrie Coghill
President (effective 01/01/2016)10Yes (X)$0$0$0Yes (X)
Kelly R Gray
Vice Chair10Yes (X)$0$0$0Yes (X)
David Kaplan
President (Through 12/31/2015)10Yes (X)$0$0$0Yes (X)
Michael Annichine
CEO (effective 04/11/2016)400Yes (X)$0$0$0Yes (X)
Yoel Sadovsky
Executive Director/Professor920Yes (X)$553,942$0$67,113Yes (X)
Arthur Scully III
Vice President400Yes (X)$191,881$0$39,628Yes (X)
Gerald Schatten
Professor400$309,853$0$43,333Yes (X)
Sharon Hillier
Professor400$304,694$0$40,759Yes (X)
Ian McGowan
Professor400$272,800$0$36,775Yes (X)
Elizabeth Krans
Assistant Professor400$171,513$0$30,381Yes (X)
Kyle Orwig
Associate Professor400$196,176$0$28,025Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,000,859TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$286,014TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K45IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other SrcsYes (1)CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Business Name Line2ContractorName/BusinessName/BusinessNameLine2TxtAddress Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmCountryContractorAddress/ForeignAddress/CountryCdProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm
University of Pittsburgh
Office of Research Cost Accounting3109 Cathedral of LearningPittsburghPA15251Medical Research$8,653,929
Medical Research Council
Medical Research$2,500,995Post Box 19070Cape TownSF
UZ-UCSF Colaborative
Univ of Zimbabwe/Univ of California InitiativeMedical Research$2,233,525BelgraviaZIHarare
Fred Hutchinson Cancer Research Center
1100 Fairview NSeattleWA98109Medical Research$2,103,822
Family Health International
Post Box 602146CharlotteNC28260Medical Research$1,706,581
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K27CntrctRcvdGreaterThan100KCnt
Info In Schedule O Part VIIIYes (X)InfoInScheduleOPartVIIIInd
Federated Campaigns$63,350FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$245,231FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$41,289,864GovernmentGrantsAmt
All Other Contributions$7,287,520AllOtherContributionsAmt
Noncash Contributions$280,983NoncashContributionsAmt
Total Contributions$48,885,965TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
Service Fee Revenue541380$355,389$355,389$0$0
Student Intern program stipend recovery541712$17,810$17,810$0$0

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$373,199TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$921,271TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$921,271ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$862,581RealAmt
Personal$0PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$862,581RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$862,581TotalRevenueColumnAmt
Related Or Exempt Func Income$862,581RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$17,843,730SecuritiesAmt
Other$0OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$16,847,077SecuritiesAmt
Other$0OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$996,653SecuritiesAmt
Other$0OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$996,653TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$996,653ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$114,511FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$245,231ContriRptFundraisingEventAmt
Fundraising Direct Expenses$242,648FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$128,137TotalRevenueColumnAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$128,137ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$51,911,532TotalRevenueColumnAmt
Related Or Exempt Func Income$1,235,780RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,789,787ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$20,328,986TotalAmt
Program Services$20,328,986ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$8,409,692TotalAmt
Program Services$8,409,692ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$540,152TotalAmt
Program Services$65,221ProgramServicesAmt
Management And General$474,931ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$10,856,310TotalAmt
Program Services$8,436,021ProgramServicesAmt
Management And General$2,216,480ManagementAndGeneralAmt
Fundraising$203,809FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$2,812,447TotalAmt
Program Services$2,237,366ProgramServicesAmt
Management And General$510,419ManagementAndGeneralAmt
Fundraising$64,662FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$23,696TotalAmt
Management And General$23,696ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$82,928TotalAmt
Management And General$82,928ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Management And General$0ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$295,217TotalAmt
Management And General$295,217ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,410,905TotalAmt
Program Services$289,020ProgramServicesAmt
Management And General$676,603ManagementAndGeneralAmt
Fundraising$445,282FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$5,700TotalAmt
Fundraising$5,700FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$448,865TotalAmt
Program Services$288,419ProgramServicesAmt
Management And General$68,209ManagementAndGeneralAmt
Fundraising$92,237FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$213,376TotalAmt
Program Services$61,760ProgramServicesAmt
Management And General$122,020ManagementAndGeneralAmt
Fundraising$29,596FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,272,702TotalAmt
Program Services$3,053,675ProgramServicesAmt
Management And General$219,027ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,122,853TotalAmt
Program Services$1,010,693ProgramServicesAmt
Management And General$41,053ManagementAndGeneralAmt
Fundraising$71,107FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$406,789TotalAmt
Program Services$406,789ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,928,128TotalAmt
Program Services$1,857,275ProgramServicesAmt
Management And General$70,208ManagementAndGeneralAmt
Fundraising$645FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Lab Equipment & Maintenance$917,463$917,463$0$0
Medical Research Supplies$1,680,519$1,680,519$0$0
Lab Testing and Processing Fees$592,511$592,511$0$0
Fundraising Expenses included in Part VIII-$242,648$0$0-$242,648

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$954,331TotalAmt
Program Services$690,788ProgramServicesAmt
Management And General$119,298ManagementAndGeneralAmt
Fundraising$144,245FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$56,060,922TotalAmt
Program Services$50,326,198ProgramServicesAmt
Management And General$4,920,089ManagementAndGeneralAmt
Fundraising$814,635FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$4,826,884BOYAmt
EOY$1,677,336EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$10,671,968BOYAmt
EOY$9,932,504EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$89,837BOYAmt
EOY$177,992EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$627,450BOYAmt
EOY$558,497EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$50,975,475LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$18,405,885LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$34,343,049BOYAmt
EOY$32,569,590EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$49,446,795BOYAmt
EOY$47,568,061EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$100,005,983BOYAmt
EOY$92,483,980EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$3,552,895BOYAmt
EOY$4,673,719EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$4,520,303BOYAmt
EOY$3,807,261EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$11,614,989BOYAmt
EOY$10,074,670EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$30,139,363BOYAmt
EOY$29,358,117EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$29,291BOYAmt
EOY$44,289EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$49,856,841BOYAmt
EOY$47,958,056EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$11,755,532BOYAmt
EOY$7,678,556EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$20,331,390BOYAmt
EOY$18,680,712EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$18,062,220BOYAmt
EOY$18,166,656EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$50,149,142BOYAmt
EOY$44,525,924EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$100,005,983BOYAmt
EOY$92,483,980EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$4,149,390ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$1,752,384NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$278,556DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$50,279,791CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$50,556,469CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$45,725,654CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,771,737CurrentTaxYearMinus1YearAmt
Current Tax Year$48,885,965CurrentTaxYearAmt
Total$254,219,616TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$50,279,791CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$50,556,469CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$45,725,654CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,771,737CurrentTaxYearMinus1YearAmt
Current Tax Year$48,885,965CurrentTaxYearAmt
Total$254,219,616TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$11,385,335SubstantialContributorsTotAmt
Public Support Total170$242,834,281PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,008,360CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,976,447CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,719,011CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,597,092CurrentTaxYearMinus1YearAmt
Current Tax Year$1,783,852CurrentTaxYearAmt
Total$9,084,762TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$263,304,378TotalSupportAmt
Gross Receipts Rltd Activities$2,999,298GrossReceiptsRltdActivitiesAmt
Public Support CY1700.92226PublicSupportCY170Pct
Public Support PY1700.93603PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$22,878,830BeginningYearBalanceAmt
Contributions$873,005ContributionsAmt
Investment Earnings Or Losses-$58,413InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$3,546,422OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$20,147,000EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$22,336,456BeginningYearBalanceAmt
Contributions$860,738ContributionsAmt
Investment Earnings Or Losses$316,392InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$634,756OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$22,878,830EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$20,383,708BeginningYearBalanceAmt
Contributions$11,625ContributionsAmt
Investment Earnings Or Losses$2,506,831InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$565,708OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$22,336,456EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$18,959,728BeginningYearBalanceAmt
Contributions$56,904ContributionsAmt
Investment Earnings Or Losses$1,897,654InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$530,578OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$20,383,708EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$19,328,380BeginningYearBalanceAmt
Contributions$18,850ContributionsAmt
Investment Earnings Or Losses-$6,643InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$380,859OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$18,959,728EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.091BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.901PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.008TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgYes (1)EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$44,437,642OtherCostOrOtherBasisAmt
Depreciation$12,977,415DepreciationAmt
Book Value$31,460,227BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$931,198OtherCostOrOtherBasisAmt
Depreciation$727,923DepreciationAmt
Book Value$203,275BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$5,606,635OtherCostOrOtherBasisAmt
Depreciation$4,700,547DepreciationAmt
Book Value$906,088BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$32,569,590TotalBookValueLandBuildingsAmt

Financial Derivatives FinancialDerivativesGrp

FieldValueIRS element (for citing)
Book Value$0BookValueAmt

Closely Held Equity Interests CloselyHeldEquityInterestsGrp

FieldValueIRS element (for citing)
Book Value$0BookValueAmt

Other Securities OtherSecuritiesGrp (6 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
Money Market$5,969,469F
Fixed Income$6,519,461F
Domestic Equity$19,246,256F
International Equity$7,522,954F
Alternative Investments$7,373,902F
Beneficial Interest in Trust$936,019F
FieldValueIRS element (for citing)
Total Book Value Securities$47,568,061TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescAgency funds held for womens AuxillaryDesc
Amt$44,289Amt
FieldValueIRS element (for citing)
Total Liability$44,289TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$50,428,417TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$1,752,384NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$321,838DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants$0RecoveriesPriorYearGrantsAmt
Other Revenue$0OtherRevenueAmt
Revenue Not Reported-$1,430,546RevenueNotReportedAmt
Revenue Subtotal$51,858,963RevenueSubtotalAmt
Investment Expenses Not Incld$295,217InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$242,648OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$52,569RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$51,911,532TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$56,051,635TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$43,282DonatedServicesUseFcltsAmt
Prior Year Adjustments$0PriorYearAdjustmentsAmt
Losses Reported$0LossesReportedAmt
Other Expenses Included$242,648OtherExpensesIncludedAmt
Expenses Not Reported$285,930ExpensesNotReportedAmt
Expenses Subtotal$55,765,705ExpensesSubtotalAmt
Investment Expenses Not Incld2$295,217InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$295,217ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$56,060,922TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part V, Line 4Endowments are used to carry out the mission of the organization, i.e., to conduct medical research related to women's health and to support the operations of Magee Womens Hospital.
Schedule D, Part XI, Line 4bFundraising expenses of $242,648 netted against revenue on 990 but included in expenses in audited Financial Statements.
Schedule D, Part XII, Line 2d$242,648 reconciling item represents fundraising expenses included in expense section of audited financials but reported as a revenue offset in Part VIII line 8 of 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Sub-Saharan Africa00Grantmaking$8,247,870
Europe (including Iceland and Greenland)00Grantmaking$90,032
East Asia and the Pacific00Grantmaking$41,790
South America00Grantmaking$30,000
FieldValueIRS element (for citing)
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Total Spent$8,409,692TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (11 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
South AmericaTo conduct clinical trials of microbicides for the prevention of HIV$30,000Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$323,430Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$1,204,772Wire Transfer$0
East Asia and the PacificTo conduct clinical trials of microbicides for the prevention of HIV$41,790Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$10,800Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$958,381Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$2,500,995Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$414,111Wire Transfer$0
Europe (including Iceland and Greenland)Characterization of meosis$90,032Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$2,233,525Wire Transfer$0
Sub-Saharan AfricaTo conduct clinical trials of microbicides for the prevention of HIV$601,856Wire Transfer$0
FieldValueIRS element (for citing)
Total501c3 Org11Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 2FormAndLineReferenceDesc
ExplanationAll grants & assistance to foreign organizations relate to collaborative biomedical research with the organizations. Each arrangement is formalized with a contract which includes specific terms & conditions that must be met. Each recipient is required to submit a detailed accounting of all expenditures incurred under the contract. This is reviewed for contract compliance and appropriateness, and only then is cash transferred to them under the grant agreement as a reimbursement. Each recipient organization is also required to submit annual reports of all research activities funded by the grant and the results of the research. This information is reviewed by the U.S. scientist who is leading the research.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1Savor PittsburghEvent1Nm
Gross Receipts Event1$220,175GrossReceiptsEvent1Amt
Charitable Contri Event1$132,399CharitableContriEvent1Amt
Gross Revenue Event1$87,776GrossRevenueEvent1Amt
Cash Prizes Event1$0CashPrizesEvent1Amt
Non Cash Prizes Event1$4,706NonCashPrizesEvent1Amt
Rent Facility Costs Event1$20,545RentFacilityCostsEvent1Amt
Food And Beverage Event1$15,385FoodAndBeverageEvent1Amt
Entertainment Event1$3,000EntertainmentEvent1Amt
Other Direct Expenses Event1$70,344OtherDirectExpensesEvent1Amt
Event2Fly fishingEvent2Nm
Gross Receipts Event2$68,500GrossReceiptsEvent2Amt
Charitable Contri Event2$53,333CharitableContriEvent2Amt
Gross Revenue Event2$15,167GrossRevenueEvent2Amt
Cash Prizes Event2$0CashPrizesEvent2Amt
Non Cash Prizes Event2$0NonCashPrizesEvent2Amt
Rent Facility Costs Event2$15,000RentFacilityCostsEvent2Amt
Food And Beverage Event2$0FoodAndBeverageEvent2Amt
Entertainment Event2$0EntertainmentEvent2Amt
Other Direct Expenses Event2$5,724OtherDirectExpensesEvent2Amt
Other Events Total5OtherEventsTotalCnt
Gross Receipts Other Events$64,468GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$54,400CharitableContriOtherEventsAmt
Gross Revenue Other Events$10,068GrossRevenueOtherEventsAmt
Cash Prizes Other Events$0CashPrizesOtherEventsAmt
Non Cash Prizes Other Events$0NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$13,267RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$14,868FoodAndBeverageOtherEventsAmt
Entertainment Other Events$0EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$4,824OthDirectExpnssOtherEventsAmt
Gross Receipts Total$353,143GrossReceiptsTotalAmt
Charitable Contributions Tot$240,132CharitableContributionsTotAmt
Gross Revenue Total Events$113,011GrossRevenueTotalEventsAmt
Cash Prizes Total Events$0CashPrizesTotalEventsAmt
Non Cash Prizes Total Events$4,706NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$48,812RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$30,253FoodAndBeverageTotalEventsAmt
Entertainment Total Events$3,000EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$80,892OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$167,663DirectExpenseSummaryEventsAmt
Net Income Summary-$54,652NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (31 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtNon Cash AssistanceNonCashAssistanceDesc
Magee Womens Hospital of UPMC
300 Halket StreetPittsburghPA15213250965420501(c)(3)$475,566$0Contribution for Hospital Activities
Brown University
Cashiers office Box 1911ProvidenceRI02912050258809501(c)(3)$16,017$0Biomedical Research
Carnegie Mellon University
Po Box 371032PittsburghPA15250250969449501(c)(3)$205,594$0Biomedical Research
Case Western University
10900 Euclid AvenueClevelandOH44106341018992501(c)(3)$24,423$0Biomedical Research
National Foundation for Center for Disease Control & Prevention
55 park Place suite 400AtlantaGA30303582106707501(c)(3)$142,496$0Biomedical Research
New York University
70 Washington Square southNew YorkNY10012135562308501(c)(3)$177,510$0Biomedical Research
Pennsylvania State University
227 W Beaver avenue Suite 401State CollegePA16801246000376501(c)(3)$27,835$0Biomedical Research
Population Council
One Dag Hammarskjold PlazaNew YorkNY10017131687001501(c)(3)$195,854$0Biomedical Research
Public Health Foundation enterprises
12801 Crossroads Pkwy SCity of IndustryCA91746952557063501(c)(3)$454,556$0Biomedical Research
Regents of the University of Michigan
500 S State StAnn ArborMI48109386006309501(c)(3)$175,844$0Biomedical Research
Research foundation for Mental Hygiene
150 BroadwayMenandsNY12204141410842501(c)(3)$318,394$0biomedical Research
Research Triangle Institute
5265 Capital BoulevardRaleighNC27616560686338501(c)(3)$819,097$0Biomedical Research
San Francisco Department of Public Health
1380 Howard StreetSan FranciscoCA94103000000000501(c)(3)$57,358$0Biomedical Research
Research Foundation for the State University of New York
PO Box 9AlbanyNY12201141368361501(c)(3)$68,899$0Biomedical Research
Tulane University
800 East Commerce RoadHarahanLA70123720423889501(c)(3)$24,020$0Biomedical Research
University of Texas
One UTSA CircleSan AntonioTX78249746000089501(c)(3)$406,313$0Biomedical Research
University of California Los Angeles
405 Hilgard AvenueLos AngelesCA90095956006143501(c)(3)$94,668$0Biomedical Research
The Regent of the University of California at Davis
1850 Research Park Drive suite 300DavisCA95618946036494501(c)(3)$28,207$0Biomedical Research
University of Alabama
1720 second Avenue SouthBirminghamAL35294636005396501(c)(3)$311,430$0Biomedical Research
University of California San Diego
9500 Gilman AvenueLa JollaCA92093956006144501(c)(3)$372,447$0Biomedical Research
University of Colorado Denver
1775 Aurora CourtDenverCO80045846000555501(c)(3)$172,319$0Biomedical Research
University of North Carolina at Chapel Hill
104 Airport DrChapel HillNC27599566001393501(c)(3)$711,121$0Biomedical Research
University of Pittsburgh
4200 fifth AvenuePittsburghPA15260250965591501(c)(3)$8,653,929$0Biomedical Research
University of Washington
Gerberding Hall G80SeattleWA98195916001537501(c)(3)$924,505$0Biomedical Research
Columbia University
116th street and BroadwayNew YorkNY10027135598093501(c)(3)$29,916$0Biomedical Research
Eastern Virginia Medical School
700 W Olney RoadNorfolkVA23507546055378501(c)(3)$15,802$0Biomedical Research
Yeshiva University
1300 Morris Park avenueBronxNY10461237075620501(c)(3)$107,324$0Biomedical Research
Emory University
954 Gatewood RoadAtlantaGA30329580566256501(c)(3)$20,370$0Biomedical Research
Family Health International
359 Blackwell StreetDurhamNC27701237413005501(c)(3)$1,706,581$0Biomedical Research
Fred Hutchinson Cancer research Center
1100 Fairview Avenue NSeattleWA98109237156071501(c)(3)$2,103,822$0Biomedical Research
John Hopkins University
733 North BroadwayBaltimoreMD21218520595110501(c)(3)$1,486,768$0Biomedical Research
FieldValueIRS element (for citing)
Total501c3 Org31Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2FormAndLineReferenceDesc
ExplanationEach recipient of grant funding enters into a contract with MWRIF. The contract details allowable uses of funds and includes a detailed budget listing anticipated expenditures. Funds are released to recipients on a cost reimbursement basis. The recipient submits a report summarizing the expenditure incurred, which is carefully reviewed by MWRIF personnel against budgets and terms of the contract before funds are released.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Club Dues Or FeesYes (X)ClubDuesOrFeesInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt
Yoel Sadovsky
Executive Director/Professor$450,387$0$100,953$0$2,602$0$47,830$0$19,283$0$621,055$0$0
Arthur Scully III
Vice President$191,281$0$0$0$600$0$23,530$0$16,098$0$231,509$0$0
Gerald Schatten
Professor$309,252$0$0$0$600$0$31,801$0$11,533$0$353,186$0$0$0
Sharon Hillier
Professor$253,744$0$50,000$0$950$0$30,450$0$10,309$0$345,453$0$0$0
Ian McGowan
Professor$222,200$0$50,000$0$600$0$32,220$0$4,555$0$309,575$0$0
Elizabeth Krans
Assistant Professor$171,000$0$0$0$513$0$20,520$0$9,861$0$201,894$0$0$0
Kyle Orwig
Associate Professor$195,576$0$0$0$600$0$23,470$0$4,555$0$224,201$0$0$0

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1aMembership dues for the Duquesne Club, a private club located in Pittsburgh's downtown business district, are paid by MWRIF for Arthur Scully, VP of Development. The Club's facility is used to host Board and Donor meetings and related events.
Schedule J, Part I, Line 3The Executive Director is dually employed by both the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). 100% of his time is spent on either his biomedical research or his Executive Director responsibilities, so MWRIF is financially responsible for his total compensation. Each of the three organizations are involved in evaluating the ED's compensation taking into account accomplishments, responsibilities, and comparison to AAMC (American Association of Medical Colleges) benchmarks. The initial salary as well as subsequent adjustments must be approved by senior management of the University and UPMC, and is also approved by select independent directors of MWRIF board. A written employment contract is used by both employers to document all employment terms including compensation. All paperwork regarding the process and approvals is maintained by the respective organizations.
Schedule J, Part I, Line 7In addition to a base compensation from each employer, Dr. Sadovsky is eligible for incentive compensation as follows: From UPMC, he is eligible for performance based incentive compensation as part of his employment contract. Performance is evaluated against a list of predetermined goals and payment is made in the subsequent fiscal year. From the University of Pittsburgh, he is eligible for a research incentive based on certain criteria established by the University for all researchers. This is tied to his own research lab and is not related to his function as Executive Director of MWRIF. Gerald Schatten, Sharon Hillier, Ian McGowan, Elizabeth Krans, and Kyle Orwig are also eligible for the University of Pittsburgh research incentive mentioned above, if they meet the criteria established by the University.
Schedule J, Part II(Also 990 Part VII, Section A): MICHAEL ANNICHINE joined the Organization as its CEO effective 04/11/2016. Since compensation information disclosed in this Form 990 Part VII and Schedule J relates to compensation paid out for the Calendar Year 2015, there is no reportable compensation for Mr. Annichine. ELIZABETH KRANS is dually employed by both the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). She divides her time between clinical work and her research pursuits. The reportable wages shown on Schedule J Part II and Part VII Line 1a represent the portion of her combined salary attributable to her research work which is the responsibility of MWRIF. UPMC is responsible for the portion of her combined salary attributable to her clinical work.

Schedule M IRS990ScheduleM

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Noncash Contributions Rpt F990$4,706NoncashContributionsRptF990Amt
Method Of Determining RevenuesRetail valueMethodOfDeterminingRevenuesTxt

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution11ContributionCnt
Noncash Contributions Rpt F990$262,907NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescFood served at EventsDesc
Contribution7ContributionCnt
Noncash Contributions Rpt F990$13,370NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (1)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I, Line 32bFormAndLineReferenceDesc
ExplanationRegistered stock brokers are used to sell stock contributions. Stock is sold immediately upon receipt.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part I, Line 5MWRIF doesn't have any employees of its own. All individuals who work in support of the mission of MWRIF are employed either by the University of Pittsburgh or the University of Pittsburgh Medical Center (UPMC). MWRIF is billed by each organization for the cost of salary and fringe benefits corresponding to the effort these individuals expend in support of the MWRIF mission. MWRIF records such costs as compensation on its financial statements. Payroll taxes are filed by the employer organizations.
Form 990, Part III, Line 4aMagee-Womens Research Institute (MWRI), the first and largest research institute in the U.S. devoted exclusively to women's health, is a recognized leader conducting unprecedented research and advancing clinical knowledge in many areas affecting women, including: reproductive biology, breast cancer, ovarian cancer, genomics and personalized therapies, HIV immunization and prevention, fertility preservation, and pelvic floor research. Magee-Womens Research Institute is dedicated to the transformation of health research for the good of all humankind. Though women comprise 50% of the population, they give birth to 100% of future generations. As researchers, this fact has led us to the realization that women's health is the key to human wellness. Remarkable for its potential to revolutionize the art and science of medicine, this insight is the foundation of the Magee Movement. By embracing this new perspective, we will develop pragmatic solutions and prevent problems once considered inevitable. We envision a future in which all physicians and researchers routinely address the genetic and gestational causes of chronic and devastating developments like diabetes and cardiovascular disease in an attempt to prevent their occurrence. We believe that our best defense against infectious disease is to empower women. We are dedicated to fostering wellness by incorporating gender-based medicine. These tenets have motivated us to refocus our research in to three pillars: PILLAR 1: 9-90: From conception onward, the first nine months of pregnancy contain the key to many of life's questions about health and well-being. Through our 9-90TM research, scientists investigate how the 9 months of pregnancy impact the next 90 years of life. The nine months in utero are so universally important because the moment of greatest plasticity - or the ability to be easily shaped or molded - is during pregnancy. It is during this time that factors such as environmental exposure, nutrition, and infection, as well as other influences, most greatly impact fetal development and leave a lasting mark. Studying this "human blueprint" allows scientists to better predict the conditions that will affect a person later in life and potentially change or cure those conditions. Areas of study in 9-90 are: REPRODUCTIVE DEVELOPMENT: Uncovering the mechanisms that underlie genetic abnormalities is crucial to reducing birth defects and improving the health of infants. PREGNANCY & NEWBORNS: A healthy start in life is the key to a lifetime of well-being. Magee scientists continue to make lifesaving discoveries about key diseases such as preeclampsia, fetal growth abnormalities, preterm birth, prenatal genetics and the lifelong impact stemming from these diseases through research spanning fetal development, pregnancy and pregnancy outcomes that shape maternal and neonatal health. REPRODUCTIVE PHYSIOLOGY & FERTILITY: Infertility is heartbreaking to the couple who desperately wants a child to love. Our scientists study the fundamental mechanisms that govern germ cell biology and complex pathways that lead to human infertility, to discover means for restoring fertility to diverse populations including young cancer survivors. GENETICS: Genetic studies of placental development are furthering medical science's understanding of how hormonal, nutritional and environmental signals in the womb influence genes that regulate all aspects of our physiology. PILLAR 2: GENDER SPECIFIC MEDICINE (GSM): For hundreds of years, scientists have been studying human disease processes while employing male research subjects almost exclusively. This approach has established a baseline for understanding, but truly effective human health research demands the study of both female and male responses to disease origin, prevention, and treatment. The differences between women and men and the distinctive ways they present with disease, respond to treatment, and recover can tell us much about how to ensure each patient receives the right treatment in the right way at the right time. Areas of study in GSM are: WOMENS CANCERS: At Magee, our response to Cancer is to find new and better ways to prevent and treat it. With recent breakthroughs in genomic discovery, we now have the tools to identify biomarkers for cancer risk, severity and prognosis. Through large scale clinical trials performed as a part of the national consortia, Magee scientists and physicians investigate ovarian and other pelvic cancers, examine the causes, prevention and treatment of breast cancer, and assess the impact cancer has on a woman's quality of life. UROGYNECOLOGY: We are unyielding in our determination to find ways to improve patient care in the treatment of the female pelvic floor. We are set on finding better treatments for conditions that affect women of reproductive age through maturity. WOMENS HEALTH & WELLNESS: An appalling one in four women will experience domestic abuse in her lifetime. Specific areas of focus include intimate partner violence, teen pregnancy, prenatal care and postpartum depression. We also pinpoint gaps in the quality of health and healthcare across racial, ethnic and socioeconomic groups that result in higher incidence of chronic diseases, higher mortality and poorer health outcomes for women. PILLAR 3: INFECTIOUS DISEASES: Magee is focusing its efforts on the global threat of infectious diseases and our clinical trials are yielding breakthrough results all over the world. Our organization receives more HIV&AIDS research funding from the NIH than any other research center in the country - and, in 2006, the NIH established the Microbicide Trials Network (MTN) at Magee-Womens Research Institute. Led by Sharon Hillier, PhD, the MTN is a worldwide collaborative clinical trials network focused on preventing the transmission of HIV. Today, eleven years later, the MTN operates more than 20 sites in Africa, Southeast Asia and the United States.
Form 990, Part VI, Section A, Line 2Directors Arthur Levine and Linda Melada have a family relationship.
Form 990, Part VI, Section B, Line 11bThe initial draft of the Form 990, which is prepared by the Accounting Manager, is reviewed by the Director of Finance. It is then reviewed externally by representative of MWRIF's external auditors Maher Duessel. After that, the Audit Committee, a sub-committee of the Board of Directors, reviews and provides a report to the Board. A copy of the Form 990 is provided to the full Board of Directors prior to filing with the IRS.
Form 990, Part VI, Section B, Line 12cThe organization has a conflict of interest policy that is driven by the classification of each individual as follows: Board members are required to sign a formal conflict of interest questionnaire annually prior to the beginning of each fiscal year for which they are a member. The forms are reviewed internally by the VP of Development and Communications and actual or potential conflicts are reported to the Board Chair. * Designated individuals (managers and above, and any employee holding a position of influence or trust) supporting MWRIF who are employed by UPMC are required to follow their employer mandated conflict of interest policy which includes annual electronic disclosures, as well as additional disclosures as related circumstances change. These are reviewed and monitored by the UPMC Ethics and Compliance Committee. If potential and actual conflicts are identified, a Conflict Management Plan must be developed and submitted to the Committee. Failure to disclose potential conflicts or to follow the approved conflict management plan will result in disciplinary action. * Designated individuals (all faculty, staff with administrator IV title or above and any others designated based on their responsibilities) working at MWRIF who are employees of the University of Pittsburgh are required to follow their employer mandated conflict of interest policy which includes annual electronic conflict of interest disclosures, as well as additional disclosures as related circumstances change. These are reviewed by the individual's department head and reported to University senior management as well as maintained by the Conflict of Interest Committee. Potential or actual conflicts are handled by the employees first line supervisor and a management plan developed. The plan is submitted to senior management as well as the COI committee for review. Sanctions may be applied for non-compliance with the requirements of the policy or with management plans, including a letter of reprimand, special monitoring of future work, removal from the particular project, probation, suspension, salary reduction, or initiation of steps leading to possible reduction in rank or termination of employment.
Form 990, Part VI, Section B, Line 15The Executive Director is dually employed by both University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). 100% of his time is spent on either his medical research (about 46 hours/week average) or on his Executive Director responsibilities (an additional 46 hours/week average), for an average total of 92 hours per week. MWRIF is financially responsible for his total compensation and it reimburses the University of Pittsburgh and UPMC for his compensation. Each of the three organizations are involved in evaluating the ED's compensation taking into consideration his accomplishments, responsibilities, and comparing against AAMC (American Association of Medical Colleges) benchmarks. The initial salary as well as any subsequent adjustments are approved by senior management of the University and UPMC and by selected external members of the MWRIF Board. All paperwork regarding the process and approvals is maintained by the respective organizations.
Form 990, Part VI, Section C, Line 19The Conflict of Interest Policy, governing documents, and financial statements are available at the Organization's business office located at 3339 Ward street, Pittsburgh, PA 15213.
Form 990, Part VIII, Line 6aThe research conducted at MWRIF occurs in a facility located at 204 Craft Avenue. UPMC owns this building and MWRIF is renting the space from them. Since the lease agreement with UPMC is long term (30 years), for accounting purposes it has to be recorded as a liability on MWRIF's books. This is the mortgage/note payable disclosed on Line 24 of Part X. The lease agreement does not contain any terms implying that MWRIF will ever own or have the option to buy the building. The rental income disclosed in Part VIII is generated by subleases between MWRIF and several research labs that are part of the University of Pittsburgh, allowing them to occupy a portion of the space MWRIF is renting from UPMC. These particular University of Pittsburgh researchers collaborate with MWRIF researchers on a regular basis on large biomedical research projects where physical proximity facilitates the collaborative process and allows them to meet, share equipment and other resources as needed to make the collaboration more efficient and hopefully more successful. The objective in renting the space to the University of Pittsburgh is to facilitate the collaboration, not to generate profit. So the rental income disclosed in Part VIII is sublease income that offsets a portion of MWRIF's lease expense. MWRIF has no acquisition indebtedness which would require the rental income to be disclosed as unrelated business income.